3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Hodgkin Disease
41
Lymphoma
16
Urinary Bladder Neoplasms
7
Melanoma
6
Prostatic Neoplasms
3
Neoplasms
3
Leukemia
3
Glioma
3
Carcinoma, Non-Small-Cell Lung
3
Testicular Neoplasms
2
Testicular Germ Cell Tumor
2
Skin Neoplasms
2
Lymphoma, Large-Cell, Anaplastic
2
Central Nervous System Neoplasms
2
Breast Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Urothelial Carcinoma of the Bladder
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Teratoma
1
Survival Without Progression
1
Seminoma
1
Rhabdoid Tumor
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pathologic Complete Response
1
Oligodendroglioma
1
Neurofibromatosis 1
1
Interventions
Vinblastine
1
Surveys and Questionnaires
1
Nivolumab
1
Cyclophosphamide
1
Cell- and Tissue-Based Therapy
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Childhood Solid Tumor
×
Vinblastine
×
Clear all
NCT03585465
2026-05-29
Metro-PD1
Centre Oscar Lambret
Phase 1/2
Terminated
63 enrolled